JS

Josh Sherman

Investor at Surveyor Capital

New York, New York

Overview 

Josh Sherman is a Public/Private Biotech Investor at Surveyor Capital, with previous roles at Longitude Capital and Apple Tree Partners. He holds an MBA from Columbia Business School and has a background in investment banking and corporate finance, specializing in sectors like medical devices, consumer health, and pharmaceuticals. Sherman's career highlights include serving as Vice President at Longitude Capital and Senior Associate at Apple Tree Partners, showcasing his expertise in biotech investments and corporate strategy & finance. Currently, he excels in financial modeling, valuation, and equity research at Surveyor Capital, focusing on investments in the healthcare sector.

Work Experience 

  • Public / Private Biotech Investor

    2022 - Current

Surveyor Capital is an investment firm that focuses on access and opportunity to companies and entrepreneurs.

  • Vice President, Biotech

    2020 - 2022

    Biotechnology Team Portfolio Responsibilities: Alpha-9 Theranostics, Avenge Bio, Inozyme (INZY), Lexeo Therapeutics, Sierra Oncology (SRRA), Theseus Pharmaceuticals (THRX)

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

  • Senior Associate

    2014 - 2019

    Apple Tree Partners (ATP) is a leading $2.5Bn life sciences venture capital firm dedicated to actively funding life sciences innovation and developing the next generation of transformative biotechnology companies. Senior Associate on the investment team focused on early to late-stage investments in biotechnology and medical devices.

Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Raised $5,000,000.00.

  • Corporate Strategy & Finance

    2016 - 2019

    Braeburn is developing long-acting medicines for the treatment of opioid addiction.

We transform the management of OUD to help people begin and sustain recovery.

Raised $133,000,000.00 from RA Capital Management, Avista Healthcare Partners, Apple Tree Partners, New Leaf Venture Partners, Deerfield Capital Management, Wellington Capital Management and Rock Springs Capital.

  • Investment Banking, Healthcare

    2013 - 2014

    Healthcare Investment Banking Group

  • Investment Banking

    2012 - 2013

    Financial Institutions Group

Morgan Stanley Venture Partners is a private equity firm that invests in high-growth companies in the technology and healthcare industries.

Articles About Josh

Relevant Websites